This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Drugs

Captain America Cruises, Allergan Surges and Amazon Teams Up

"Captain America: The Winter Soldier" topped the box office again last weekend, while Amazon is teaming up with HBO to make its hit shows available to its prime members starting in late May.

04/24/14 - 08:00 PM EDT

Gilead's Earnings: Diving Deeper Into The Numbers With $84,000 Sovaldi Drug

Gilead released its first quarter earnings and the pharmaceuticals company did not disappoint. However, there is a lot more behind the numbers, especially with their $84,000-a-bottle Sovaldi drug.

04/23/14 - 06:30 PM EDT

Try Jim Cramer's Action Alerts PLUS
How Obamacare Will Play Out for Big Pharma

How Obamacare Will Play Out for Big Pharma

Obamacare could significantly impact on the ability of pharma giants to sustain their pace of curative and life-saving innovations.

04/23/14 - 06:00 AM EDT

Article
Pershing Square and Valeant's Allergan Deal a Watershed for Activism

Pershing Square and Valeant's Allergan Deal a Watershed for Activism

  • Tickers in this article:
  • AGN
  • VRX

Pershing Square Capital Management may be re-writing the rules of activist investing after teaming up with Valeant Pharmaceuticals on a potential takeover of Allergan.

04/22/14 - 01:36 PM EDT

Article
Why Novartis (NVS) Stock Is Up Today

Why Novartis (NVS) Stock Is Up Today

  • Tickers in this article:
  • NVS

Novartis (NVS) stock is gaining on Tuesday after announcing a series of major deals with GlaxoSmithKline (GSK) and Eli Lilly (LLY) which will reshape the pharmaceutical industry.

04/22/14 - 12:09 PM EDT

Article
Why GW Pharmaceuticals (GWPH) Stock Is Soaring Today

Why GW Pharmaceuticals (GWPH) Stock Is Soaring Today

  • Tickers in this article:
  • GWPH

GW Pharmaceuticals (GWPH) shares are popping following coverage initiation at 'overweight' by analysts at Morgan Stanley (MS)

04/22/14 - 11:18 AM EDT

Article
Bill Ackman Wants to Plump His Portfolio With Botox Maker in Hostile Takeover

Bill Ackman Wants to Plump His Portfolio With Botox Maker in Hostile Takeover

The hedge-fund manager and Valeant Pharmaceuticals have teamed up to go after Allergan.

04/22/14 - 10:47 AM EDT

Article
Amgen, AT&T and Yum! Brands Lead Today's Earnings: Crunching the Numbers

Amgen, AT&T and Yum! Brands Lead Today's Earnings: Crunching the Numbers

Cree, Discover, Gilead Sciences, Intuitive Surgical, Juniper Networks, Skyworks Solutions and VMWare also report earnings after the closing bell today.

04/22/14 - 08:51 AM EDT

Article
April 22 Premarket Briefing: 10 Things You Should Know

April 22 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are lower; Valeant is teaming up with activist investor Bill Ackman in a bid for Allergan; Novartis to buy GlaxoSmithKline's cancer-drug business for $14.5 billion; Netflix posts mixed first-quarter earnings.

04/22/14 - 08:01 AM EDT

Video
European Markets Recover, On a Dose of Pharmaceuticals European Markets Recover, On a Dose of Pharmaceuticals

The main European markets rise on news and rumors of pharmaceutical deals. Novartis, GlaxoSmithKline and Eli Lilly work a three-way asset swap.

04/22/14 - 07:43 AM EDT

Article
Emerging 'Superbugs' -- and Why Investors Should Care

Emerging 'Superbugs' -- and Why Investors Should Care

Antibiotic-resistant 'superbugs' are spreading, and drug companies and their investors should take notice.

04/21/14 - 12:23 PM EDT

Video
Pfizer Ready to Spend Cash and Sarepta Readies MS Drug Pfizer Ready to Spend Cash and Sarepta Readies MS Drug

Pfizer rumored deal for Astra Zeneca said to be rejected, while Sarepta gets a boost from the FDA.

04/21/14 - 10:03 AM EDT

Article
April 21 Premarket Briefing: 10 Things You Should Know

April 21 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are rising; Pfizer reportedly hold informal talks about a merger with AstraZeneca; Kraft Foods recalls 96,000 pounds of hot dogs; Netflix to report earnings; GM boosts production in China.

04/21/14 - 06:47 AM EDT

Video
The LinkedIn of Marijuana Connects Job Seekers With Cannabis Employers The LinkedIn of Marijuana Connects Job Seekers With Cannabis Employers

Intelligent Living is a platform company with four subsidiaries, including one called social420.com. It's the LinkedIn for professionals in the cannabis industry.

04/19/14 - 04:00 PM EDT

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 16,501.65 0.00 0.00%
S&P 500 1,878.61 +3.22 0.17%
NASDAQ 4,148.3380 +21.3710 0.52%

Brokerage Partners

Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs